04 Nov 2021

Inmunoterapia & Hemopatías 2021

Stay Tuned!

Our Newsletter
Microscope
Hemopathies
Microphone
Course
Wolrd
Spanish
Empty or Forbidden
Event Finished
Price:
Free
Do you want to know the next activities activities on Inmunoterapia & Hemopaties?

Join our newsletter list to be updated on upcoming activities.

The use of uni- or bispecific monoclonal antibodies, antibodies capable of blocking immune-checkpoints, or the use of genetically modified T lymphocytes or NK cells designed to destroy tumor cells (CART), have brought about a true revolution in cancer treatment. Currently, new therapies based on the identification of tumor neoantigens and the development of personalized therapeutic […]

The use of uni- or bispecific monoclonal antibodies, antibodies capable of blocking immune-checkpoints, or the use of genetically modified T lymphocytes or NK cells designed to destroy tumor cells (CART), have brought about a true revolution in cancer treatment. Currently, new therapies based on the identification of tumor neoantigens and the development of personalized therapeutic vaccines are showing very promising results. The use of immunotherapy is reaching its maximum development in hematological diseases due to the fact that tumor cells can more easily come into contact with the normal immune cells responsible for their destruction.

The conference aims to deepen the knowledge of the use of immunotherapy in the treatment of hematopathies, providing an integrative vision between the clinical/basic knowledge of the pathology and the function of the immune system.

The course is aimed at researchers and residents in hematology, oncology and immunology.

Accreditation

Activity accredited by the Consell Català de Formació Continua de les Professions Sanitàries-Comisión de Formación Continuada de Sistema Nacional de Salud. 0,8 Credits. Record: 09/029964-MD.

Organizers

Sponsors

0
    0
    Your Cart
    Your cart is emptyReturn to Shop